FDA Announces Plan to Phase Out Animal Testing. Will That Work? – New Study
Human organs-on-chips and organoids offer new alternatives to animals for drug development, but there is still a long way to go.
Summary
Human organ-on-chips and organoids are emerging as promising alternatives to animal testing in drug development. These miniature, lab-grown models mimic the structure and function of human organs, offering more relevant insights into drug efficacy and toxicity. However, these technologies are still in their early stages of development and refinement. Challenges remain in replicating the complexity of whole organs and ensuring the reliability and reproducibility of results. While holding significant potential to reduce reliance on animal models, further research and validation are necessary before widespread adoption in drug development pipelines.
Read more…
This post is part of “Science and Technology News”, Follow for more…!!!
Credits: Source
Disclaimer